Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.97 USD | +13.72% |
|
+25.34% | +103.20% |
06-20 | Nurix Therapeutics Insider Sold Shares Worth $400,216, According to a Recent SEC Filing | MT |
06-18 | HC Wainwright Raises Price Target on Nurix Therapeutics to $26 From $19, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.20% | 1.19B | |
+15.85% | 121B | |
+18.91% | 112B | |
+4.43% | 22.57B | |
-18.63% | 20.82B | |
-13.76% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+1.75% | 13.17B | |
+28.07% | 11.11B |
- Stock Market
- Equities
- NRIX Stock
- News Nurix Therapeutics, Inc.
- Nurix Therapeutics Names New Board Chair